SCHEMBL5044800

SCHEMBL5044800

CCCCCCC/C=C/CCCCCCO

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.68
HSD17B10 Q99714 3/20 0.68
KMT2A Q03164 3/20 0.68
MEN1 O00255 2/20 0.68
ALDH1A1 P00352 1/20 0.68
TSHR P16473 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.63
FAAH O00519 4/20 0.58
TRPV1 Q8NER1 1/20 0.58
TERT O14746 3/20 0.56
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
FABP4 P15090 2/20 0.56
PTPN1 P18031 2/20 0.56
PPARG P37231 2/20 0.56
PPARD Q03181 2/20 0.56
PPARA Q07869 2/20 0.56
GMNN O75496 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039239 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL833160 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL1302194 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL5361747 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL22616793 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL24450559 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL5040020 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL2933864 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL21065749 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1
SCHEMBL4881870 1.00 LMNA (0.68) LMNAHSD17B10KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1850670-A4 FORMULATIONS USEFUL FOR THE TREATMENT OF VARICELLA ZOSTER VIRUS INFECTIONS AND METHODS FOR THE USE THEREOF VERBISCAR ANTHONY J (US) 2008-08-06 EP claimed
EP-1850670-A1 FORMULATIONS USEFUL FOR THE TREATMENT OF VARICELLA ZOSTER VIRUS INFECTIONS AND METHODS FOR THE USE THEREOF Verbiscar, Anthony, J. (US) 2007-11-07 EP claimed
WO-2006112938-A1 FORMULATIONS USEFUL FOR THE TREATMENT OF VARICELLA ZOSTER VIRUS INFECTIONS AND METHODS FOR THE USE THEREOF VERBISCAR ANTHONY J (US) 2006-10-26 WO claimed
US-20050203187-A1 Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof VERBISCAR ANTHONY J (US) 2005-09-15 US claimed
EP-1850670-A4 FORMULATIONS USEFUL FOR THE TREATMENT OF VARICELLA ZOSTER VIRUS INFECTIONS AND METHODS FOR THE USE THEREOF VERBISCAR ANTHONY J (US) 2008-08-06 EP disclosed
EP-1850670-A1 FORMULATIONS USEFUL FOR THE TREATMENT OF VARICELLA ZOSTER VIRUS INFECTIONS AND METHODS FOR THE USE THEREOF Verbiscar, Anthony, J. (US) 2007-11-07 EP disclosed
WO-2006112938-A1 FORMULATIONS USEFUL FOR THE TREATMENT OF VARICELLA ZOSTER VIRUS INFECTIONS AND METHODS FOR THE USE THEREOF VERBISCAR ANTHONY J (US) 2006-10-26 WO disclosed
US-20050203187-A1 Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof VERBISCAR ANTHONY J (US) 2005-09-15 US disclosed